Tumor Volume, Tumor Percentage Involvement, or Prostate Volume: Which Is Predictive of Prostate-specific Antigen Recurrence?

Urology

Volumn 75, Issue 2, 2010, Pages 460-466

  Uhlman, Matthew A ^a   Sun, Leon ^a   Stackhouse, Danielle A ^a   Caire, Arthur A ^a   Polascik, Thomas J ^a   Robertson, Cary N ^a   Madden, John ^a   Vollmer, Robin ^a   Albala, David M ^a   Moul, Judd W ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; GLEASON SCORE; HUMAN; HUMAN TISSUE; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATECTOMY; SEMINAL VESICLE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGAN SIZE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 75349098442     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.06.059     Document Type: Article

References (30)

1. Nelson B.A., Shappell S.B., Chang S.S., et al. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer. BJU Int 97 (2006) 1169-1172
2. Stamey T.A., McNeal J.E., Yemoto C.M., et al. Biological determinants of cancer progression in men with prostate cancer. J Am Med Assoc 281 (1999) 1395-1400
3. Chun F.K., Briganti A., Jeldres C., et al. Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy. Eur J Cancer 43 (2007) 536-543
4. Vollmer R.T. Percentage of tumor in prostatectomy specimens: a study of American veterans. Am J Clin Pathol 131 (2009) 86-91
5. Kikuchi E., Scardino P.T., Wheeler T.M., et al. Is tumor volume an independent prognostic factor in clinically localized prostate cancer?. J Urol 172 (2004) 508-511
6. May M., Siegsmund M., Hammermann F., et al. Visual estimation of the tumor volume in prostate cancer: a useful means for predicting biochemical-free survival after radical prostatectomy?. Prostate Cancer Prostatic Dis 10 (2007) 66-71
7. Merrill M.M., Lane B.R., Reuther A.M., et al. Tumor volume does not predict for biochemical recurrence after radical prostatectomy in patients with surgical Gleason score 6 or less prostate cancer. Urology 70 (2007) 294-298
8. Carvalhal G.F., Humphrey P.A., Thorson P., et al. Visual estimate of the percentage of carcinoma is an independent predictor of prostate carcinoma recurrence after radical prostatectomy. Cancer 89 (2000) 1308-1314
9. Ramos C.G., Roehl K.A., Antenor J.A., et al. Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer. J Urol 172 (2004) 137-140
10. Rampersaud E.N., Sun L., Moul J.W., et al. Percent tumor involvement and risk of biochemical progression after radical prostatectomy. J Urol 180 (2008) 571-576 discussion:576
11. Epstein J.I., Carmichael M., Partin A.W., et al. Is tumor volume an independent predictor of progression following radical prostatectomy?. A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of follow up. J Urol 149 (1993) 1478-1481
12. Schroeck F.R., Sun L., Freedland S.J., et al. Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy. Prostate Cancer Prostatic Dis 11 (2008) 371-376
13. Stamey T.A., Yemoto C.M., McNeal J.E., et al. Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens. J Urol 163 (2000) 1155-1160
14. Freedland S.J., Isaacs W.B., Platz E.A., et al. Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study. J Clin Oncol 23 (2005) 7546-7554
15. 3 predicts for a favorable outcome after radical prostatectomy for localized prostate cancer. Urology 52 (1998) 631-636
16. Foley C.L., Bott S.R., Thomas K., et al. A large prostate at radical retropubic prostatectomy does not adversely affect cancer control, continence or potency rates. BJU Int 92 (2003) 370-374
17. Cookson M.S., Aus G., Burnett A.L., et al. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 177 (2007) 540-545
18. Zeng J., Bauer J., Yao X., et al. Building an accurate 3D map of prostate cancer using computerized models of 280 whole-mounted radical prostatectomy specimens. Proceedings of the SPIE Medical Imaging Conference 3976 (2000) 466-477
19. True L.D. Surgical pathology examination of the prostate gland. Practice survey by American Society of Clinical Pathologists. Am J Clin Pathol 102 (1994) 572-579
20. Kattan M.W., Eastham J.A., Stapleton A.M., et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 90 (1998) 766-771
21. Stephenson A.J., Scardino P.T., Eastham J.A., et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 23 (2005) 7005-7012
22. Massengill J.C., Sun L., Moul J.W., et al. Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. J Urol 169 (2003) 1670-1675
23. Yadav R., Tu J.J., Jhaveri J., et al. Prostate volume and the incidence of extraprostatic extension: is there a relation?. J Endourol 23 (2009) 383-386
24. Descazeaud A., Zerbib M., Vieillefond A., et al. (The low weight of the prostate is an independent risk factor for positive surgical margins on radical prostatectomy specimens). Prog Urol 17 (2007) 203-207
25. Tanagho E.A., and McAninch J.W. Smith's General Urology (2004), Lange Medical/McGraw-Hill, New York 758
26. Wein A., Kavoussi L., Novick A., et al. Campbell-Walsh Urology vol 3 (2007), Saunders Elsevier, Philadelphia, PA
27. Steuber T., Erbersdobler A., Graefen M., et al. Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy. Cancer 106 (2006) 775-782
28. Suardi N., Porter C.R., Reuther A.M., et al. A nomogram predicting long-term biochemical recurrence after radical prostatectomy. Cancer 112 (2008) 1254-1263
29. Efstathiou J.A., Chen M.H., Catalona W.J., et al. Prostate-specific antigen-based serial screening may decrease prostate cancer-specific mortality. Urology 68 (2006) 342-347
30. Schroder F.H., Hugosson J., Roobol M.J., et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360 (2009) 1320-1328